Loading...

VolitionRx Limited

VNRX•AMEX
Healthcare
Medical - Diagnostics & Research
$0.73
$-0.02(-2.63%)

VolitionRx Limited (VNRX) Company Profile & Overview

Explore VolitionRx Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

VolitionRx Limited (VNRX) Company Profile & Overview

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOCameron Reynolds MBA

Contact Information

https://www.volition.com
646 650 1351
13215 Bee Cave Parkway, Henderson, TX, 78738

Company Facts

85 Employees
IPO DateMar 2, 2012
CountryUS
Actively Trading

Frequently Asked Questions

;